out insurance eligibility support. For more information, please call 1-844-PRALUENT (1-844-772-5836Ca). Earlier today, the companies announced that the European Medicine Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for the marketing authorization of Praluent, recommend